It is well established that spliceosome mutations, such as SRSF2, are mutually exclusive among them but they usually coexist with mutations in epigenetic modifiers, cooperating to give rise to the MDS phenotype [29]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.